IMVT

Immunovant, Inc.

Next Earnings

Aug 20, 2026

Net Activity (1Y)

-$18.4M

Net Activity (90D)

-$18.1M

Insider Activity Graph

(25 shown · 61 raw)

Green/Red bubbles = daily net insider value (size = magnitude), Blue line = daily close price, E = earnings-related SEC filing

Insider trades for this company
Insider	Title	Type	Date ↓	Shares	Value
Christopher Van Tuyl	Chief Legal Officer	Sale	2026-06-18	2,634	$93K
Atul Pande	—	Sale	2026-06-15	1,500	$51K
Andrew J. Fromkin	—	Sale	2026-05-28	221,951	$7.4M
Atul Pande	—	Sale	2026-05-20	6,000	$192K
Melanie Gloria	Chief Operating Officer	Sale	2026-05-20	3,115	$101K
Robert Graham Susman	—	Sale	2026-05-01	2,502	$68K
Tiago Girao	Chief Financial Officer	Sale	2026-04-23	25,760	$763K
Jay S Stout	Chief Technology Officer	Sale	2026-04-23	2,754	$82K
Jay S Stout	Chief Technology Officer	Sale	2026-04-08	10,132	$252K
Melanie Gloria	Chief Operating Officer	Sale	2026-04-08	8,722	$217K
Christopher Van Tuyl	Chief Legal Officer	Sale	2026-04-08	5,165	$128K
Eric Venker	Chief Executive Officer	Sale	2026-04-02	14,229	$343K
Eric Venker	Chief Executive Officer	Disposition	2026-04-01	334,960	$8.4M
Christopher Van Tuyl	Chief Legal Officer	Sale	2026-03-18	2,877	$72K
Melanie Gloria	Chief Operating Officer	Sale	2026-02-25	3,238	$90K
Jay S Stout	Chief Technology Officer	Sale	2026-01-21	1,977	$51K
Jay S Stout	Chief Technology Officer	Sale	2026-01-07	1,203	$32K